Drug
Pertuzumab
Pertuzumab: highest development phase Phase 3, developed by Roche, Zydus. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche, Zydus
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pertuzumab NCT02320435 | Phase 3 | Solid Tumors |
| Pertuzumab (ZRC-3277) NCT05283837 | Phase 3 | Metastatic Breast Cancer |
Latest
No recent events.
Follow Pertuzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.